期刊文献+

急性心肌梗死患者内皮炎症与无复流及冠脉病变严重程度的相关性 被引量:20

Correlation of endothelial inflammation in patients with acute myocardial infarction with no-reflow and severity of coronary lesion
暂未订购
导出
摘要 目的研究急性心肌梗死(AMI)患者内皮炎症与无复流及冠脉病变严重程度的相关性。方法入选行经皮冠状动脉介入(PCI)治疗的AMI患者120例,其中术中出现无复流的患者40例为病例组,未出现无复流的AMI患者80例作为对照组。无复流组又根据冠状动脉造影结果分为单支病变组14例、两支病变组10例和三支病变组16例。分别采用流式细胞术和ELISA方法对上述患者术后即刻循环血内皮微粒(EMPs)及可溶性细胞间粘附分子-1(sICAM-1)水平进行测定。结果病例组PCI术后即刻循环血EMPs及sICAM-1水平均高于对照组,差异具有统计学意义。病例组EMPs和sICAM-1曲线下面积分别为0.755和0.701,表明EMPs和sICAM-1水平与AMI患者PCI术后发生无复流具有良好的相关性。冠脉病变Gensini积分和EMPs随病变支数的增加呈上升趋势,且EMPs水平与Gensini积分呈正相关。结论 AMI患者循环血EMPs及sICAM-1水平能够较好地预测无复流的发生,并对冠脉病变的严重程度也有较好的预测价值。 Objective To investigate the correlation of endothelial inflammation in patients with acute myocardial infarction (AMI) with no-reflow and severity of coronary lesion. Methods A total of 120 patients with AMI were all treated with percutaneous coronary intervention (PCI). The patients who had intraoperative no- reflow were in case group (n = 40). The patients who were also treated by PCI but did not have no-reflow in the same period in our hospital served as the control group (n =80). According to the results of coronary angiography, no-reflow group patients were divided into three subgroups: single lesion group (n = 14), two-lesion group (n = 10), and three-lesion group (n = 16). We monitored these patients' immediate postoperative endothelial microparticles (EMPs) and so}ublc intercellular adhesion molecule-1 (sICAM-1) levels in both groups with flow eytometry and ELISA methods. Results In the case group, immediate postoperative EMPs and sICAM-1 levels in the blood circulation were significantly higher than those in the control group. EMPs area and SICAM-1 area under the curve in the case group were 0. 755 and 0. 701, which showed that EMPs and sICAM-1 levels had a good correlation with the occurrence of non-reflow in AMI patients after PCI. Gensini score and EMPs level rose with the increase of the lesion counts, and the level of EMPs was positively correlated with Gensini score. Conclusion In patients with AMI, the EMPs and slCAM-1 levels can well predict the occurrence of no-reflow and are of some value in predicting the severity of coronary lesion.
出处 《西安交通大学学报(医学版)》 CAS CSCD 北大核心 2016年第3期331-335,共5页 Journal of Xi’an Jiaotong University(Medical Sciences)
基金 延安市市级科技计划项目(No.2013-kw02)~~
关键词 内皮微粒 可溶性细胞间粘附分子-1 急性心肌梗死 无复流 GENSINI积分 endothelial microparticle soluble intercellular adhesion molecule-I acute myocardial infarction no-reflow Gensini score
  • 相关文献

参考文献14

  • 1REFFELMANN T,KLONER RA.The no-reflow phenomenon:a basic mechanism of myocardial ischemia and reperfusion[J].Basic Res Cardiol,2006,101(5):359-372.
  • 2MAKSIMENKO AV,TURASHEV AD.No-reflow phenomenon and endothelial glycocalyx of microcirculantion[J].Biochem Res Int,2012,doi:10.1155/2012/859231.
  • 3NICCOLI G,BURZOTTA F,GALIUTO L,et al.Myocardial no-reflow in humans[J].J Am Coll Cardiol,2009,54(4):281-292.
  • 4PRASAD A,GERSH BJ.Management of microvascular dysfunction and reperfusion injury[J].Heart,2005,91(12):1530-1532.
  • 5陆永光,李浪,符春晖,严华,苏强,陈妍梅,黄军章.冠心病患者内皮细胞微粒水平与Th1/Th2细胞因子水平的关系研究[J].中国全科医学,2013,16(8):878-880. 被引量:8
  • 6沈红元,陈玉蓉,沈建林.冠心病患者内皮细胞膜微粒及Th细胞因子水平变化及意义[J].检验医学与临床,2015,12(3):360-362. 被引量:8
  • 7李红昆,陆永光.内皮细胞微粒与冠心病关系的研究进展[J].广西医学,2013,35(1):104-106. 被引量:11
  • 8NOZAKI T,SUGIYAMA S,KOGA H,et al.Significance of a multiple biomarkers strategy including endothelial dysfunction to improve risk stratification for cardiovascular events in patients at high risk for coronary heart disease[J].J Am Coll Cardiol,2009,54(7):601-608.
  • 9WANG JM,HUANG YJ,WANG Y,et al.Increased circulating CD31+/CD42 microparticles are associated with impaired systemic artery elasticity in healthy subjects[J].Am J Hypert,2007,20(9):957-964.
  • 10RIDKER PM.Inflammation,infection and cardiovascular risk:how good is the clinical evidence editorial[J].Circulation,1998,97(17):1671-1673.

二级参考文献50

  • 1Guo M,Mao X,Ji Q. Inhibition of IFN regulatory factor-1 down-regulate Th1 cell function in patients with acute coronary syndrome[J].Journal of Clinical Immunology,2010,(02):241-252.
  • 2Boulanger CM,Leroyer AS,Amabile N. Circulating endothelial microparticles:a new marker of vascular injury[J].Annales de Cardiologie et d Angeiologie(Paris),2008,(03):149-154.
  • 3Zhao Z,Wu Y,Cheng M. Activation of Th17/Th1 and Th1,but not Th17,is associated with the acute cardiac event in patients with acute coronary syndrome[J].Atherosclerosis,2011,(02):518-524.
  • 4Martinez MC,Tual-Chalot S,Leonetti D. Microparticles:targets and tools in cardiovascular disease[J].Trends in Pharmacological Sciences,2011,(11):659-665.
  • 5Lacroix R,Dignat-George F. Microparticles as a circulating source of procoagulant and fibrinolytic activities in the circulation[J].Thrombosis Research,2012,(Suppl 2):S27-S29.
  • 6Chironi GN,Boulanger CM,Simon A. Endothelial microparticles in diseases[J].Cell and Tissue Research,2009,(01):143-151.
  • 7Angelot F,Seilles E,Biichle S. Endothelial cell-derived microparticles induce plasmacytoid dendritic cell maturation:potential implications in inflammatory diseases[J].Haematologica,2009,(11):1502-1512.
  • 8Jaffer FA,Calfon MA,Rosenthal A. Two-dimensional intravascular near-infrared fluorescence molecular imaging of inflammation in atherosclerosis and stent-induced vascular injury[J].Journal of the American College of Cardiology,2011,(25):2516-2526.
  • 9Rioufol G,Finet G,Ginon I. Multiple atherosclerotic plaque rupture in acute coronary syndrome:a three-vessel intravascular ultrasound study[J].Circulation,2002,(07):804-808.
  • 10Osto E,Coppolino G,Volpe M. Restoring the dysfunctional endothelium[J].Current Pharmaceutical Design,2007,(10):1053-1068.

共引文献22

同被引文献195

  • 1程丹.血清CRP联合cTnI检验在急性心肌梗死诊断中的应用观察[J].内蒙古医学杂志,2020(7):786-788. 被引量:3
  • 2邱悦群,钟一鸣.复方丹参滴丸对老年急性心肌梗死急诊冠状动脉介入治疗的影响[J].中国医院用药评价与分析,2007,7(5):376-377. 被引量:3
  • 3Stolfo D,Cinquetti M,Merlo M,et al.ST-elevation myocardial infarction with reduced left ventricular ejection fraction:Insights into persisting left ventricular dysfunction.A pPCI-registry analysis[J].Int J Cardiol,2016,15(215):340-345.
  • 4Mangion K,Corcoran D,Carrick D,et al.New perspectives on the role of cardiac magnetic resonance imaging to evaluate myocardial salvage and myocardial hemorrhage after acute reperfused ST-elevation myocardial infarction[J].Expert Rev Cardiovasc Ther,2016,14(7):843-54.
  • 5Galli A,Lombardi F.Postinfarct Left Ventricular Remodelling:A Prevailing Cause of Heart Failure[J].Cardiol Res Pract,2016,2016:2579832.
  • 6Ji MH,Tong JH,Tan YH,et al.Erythropoietin Pretreatment Attenuates Seawater Aspiration-Induced Acute Lung Injury in Rats[J].Inflammation,2016,39(1):447-456.
  • 7Khalil SK,Amer HA,El Behairy AM,et al.Oxidative stress during erythropoietin hyporesponsiveness anemia at end stage renal disease:Molecular and biochemical studies[J].J Adv Res,2016,7(3):348-358.
  • 8González GE,Wilensky L,Cassaglia P,et al.Early administration of Enalapril prevents diastolic dysfunction and ventricular remodeling in rabbits with myocardial infarction[J].Cardiovasc Pathol,2016,25(3):208-213.
  • 9Bière L,Donal E,Jacquier A,et al.A new look at left ventricular remodeling definition by cardiac imaging[J].Int J Cardiol,2016,15(209):17-19.
  • 10Jun JH,Jun NH,Shim JK,et al.Erythropoietin protects myocardium against ischemia-reperfusion injury under moderate hyperglycemia[J].Eur J Pharmacol,2014,15(745):1-9.

引证文献20

二级引证文献245

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部